Prof. Dr. Andreas Fallgatter
Andreas J. Fallgatter (born 1963)
Education and professional experience
1989: Medical Degree, University of Frankfurt (Germany)
1990: General medicine Darmstadt.
1991-1993: Neurology Hospital Trier (Germany)
1994-2010: Department of Psychiatry and Psychotherapy, University of Würzburg (Germany), with
Bavarian Clinical Board Exam in Neurology (1995) and in Psychiatry and Psychotherapy (1998)
1998-2010: Senior Physician / Consultant, Psychiatry and Psychotherapy, Univ. of Würzburg 2005-2010: Professor and Vice Director, Dept. of Psychiatry and Psychotherapy, Univ. of Würzburg
2010-present: Professor and Director, Dept. of Psychiatry and Psychotherapy, University of Tübingen
Since 2010: Head, University Hospital of Psychiatry and Psychotherapy, University of Tübingen (Germany). With >50 MDs and > 30 psychologists, the department provides in-patient treatment for all psychiatric disorders in the area of Tübingen (220.000 inhabitants) and has 164 in-patient beds and 58 day treatment places. Since 2012: elected member of the DFG (Deutsche Forschungsgemeinschaft) Section Neuroscience.
RECENT RESEARCH GRANTS 2010-2013 Clinical and neurobiological effects of NIRS controlled transcranial magnetic stimulation in patients with panic disorder during CBT treatment; BMBF. 2011-2013 Modulation of cognitive control: Predictors of transcranial direct current stimulation (tDCS) effects in major depression; CIN, DFG. 2011-2013 Action monitoring and response control in heavy and light social drinkers; CIN, DFG. 2012 Principal Investigator at Graduate School GSC1028, LEAD, and member in excellence cluster EXC307, CIN2 2013-2016 Optimisation of functional near-infrared spectroscopy; DFG. 2013-2016 Neurofeedback for adults with ADHD; DFG. 2013-2016 Patient-derived neurons as a novel test system for schizophrenia drug development, PONS; Eurostars-Eureka. 2014-2017 Influence of COMT on emotional processing in ADHD; DFG.
MAIN DOMAINS OF RESEARCH
To elucidate the neurobiological basis as well as the treatment response including psychotherapy of psychiatric disorders including schizophrenia, depression, bipolar disorder, anxiety disorders, addiction disorders, dementia, ADHD and OCD, the methodological spectrum comprises brain activation measurements (EEG, ERP, NIRS, fMRI), non-invasive brain stimulation methods (rTMS, tDCS), neuropsychological assessments as well as molecular analyses.
SELECTED PUBLICATIONS (5 out of 246)
Baehne CG*, Ehlis A-C*, Plichta MM, Conzelmann A, Pauli P, Jacob C, Gutknecht L, Lesch K-P, Fallgatter AJ (2009) Tph2 gene variants modulate response control processes in adult ADHD patients and healthy individuals. Molecular Psychiatry 14(11):1032-9.
Hahn T, Dresler T, Plichta MM, Ehlis A-C, Ernst LH, Markulin F, Polak T, Blaimer M, Deckert J, Lesch K-P, Jakob PM, Fallgatter AJ (2010) Functional amygdala-hippocampus connectivity during anticipation of aversive events is associated with Gray’s trait sensitivity to punishment. Biological Psychiatry 68(5):459-64.
Hahn T, Marquand AF, Ehlis A-C, Dresler T, Kittel-Schneider S, Jarczok T, Lesch K-P, Jakob PM, Mourao-Miranda J, Brammer MJ, Fallgatter AJ (2011) Integrating neurobiological markers of depression: a two-level classification approach. Archives of General Psychiatry 68(4):361-8.
Hahn T, Heinzel S, Plichta MM, Reif A, Lesch K-P, Fallgatter AJ (2011) Neurovascular coupling in the human visual cortex is modulated by cyclooxygenase 1 (COX-1) gene variant. Cerebral Cortex 21(7):1659-66.
Heinzel S, Haeussinger FB, Hahn T, Ehlis AC, Plichta MM, Fallgatter AJ (2013) Variability of (functional) hemodynamics as measured with simultaneous fNIRS and fMRI during intertemporal choice. Neuroimage 71:125-34.